HOMEVULNERABILITIESCVE-2024-30939
MEDIUM

CVE-2024-30939

CWE-287Published: April 25, 2024· Updated: Jun 17, 2026

6.8
CVSS v3.1

Official Description

An issue discovered in Yealink VP59 Teams Editions with firmware version 91.15.0.118 allows a physically proximate attacker to gain control of an account via a flaw in the factory reset procedure.

NVD Source

Technical Analysis

CVE-2024-30939 requires local access, meaning attackers must already have a foothold on the target system.

The vulnerability requires no privileges and no user interaction, making it a prime target for automated exploitation campaigns and worm-like propagation.

A successful exploit results in complete confidentiality breach (data exposure), full integrity compromise (data manipulation), availability disruption (denial of service), with a CVSS base score of 6.8.

From a weakness classification perspective (CWE-287): Authentication bypass vulnerabilities allow attackers to access protected resources without valid credentials.

CVSS v3.1 Vector Breakdown

Exploitability
Attack VectorPhysical
Attack ComplexityLow
Privileges Req.None
User InteractionNone
ScopeUnchanged
Impact
ConfidentialityHigh
IntegrityHigh
AvailabilityHigh
CVSS:3.1/AV:P/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H

Affected Vendors & Products

yealink1 product(s)
vp59 firmware
Source: NVD CPE · 1 total CPE entries

Exploit & PoC Resources

NO KNOWN EXPLOITNo public exploit confirmed at this time
External links open in a new tab. Always verify in a controlled environment before use.

Official Patches & Advisories

All References (2)

Quick Facts

CVE IDCVE-2024-30939
CVSS Score6.8 / 10
SeverityMEDIUM
WeaknessCWE-287
CISA KEVNo
Affected1 vendor(s)
PublishedApr 25, 2024

Related CVEs (CWE-287)

Recommended Actions

  • Apply vendor patches immediately
  • Monitor CVE-2024-30939 in threat intel feeds
  • Review IDS/IPS signatures for exploitation attempts
Data sourced from NVD (NIST), CISA KEV, and EPSS (FIRST). Analysis generated by CTIWATCH.COM. CVE data is provided under the NVD usage policy.